IPO Synopsis


Sai Parenteral's Ltd

Registered Office: No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli, Rangareddy - 500032, Telangana, India.
Phone : +91 79979 91301   Fax:
Email :  cs@saiparenterals.com  
Website :  https://www.saiparenterals.com

Initial public offer of up to 10428288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating up to Rs. 408.79 Crore comprising a fresh issue of up to 7270408 equity shares of face value of Rs. 5 each aggregating up to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of up to 3,157,880 equity shares of face value of Rs. 5 each aggregating up to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute [*]% of the post-offer paid up equity share capital of the company. Price Band: Rs. 392 per equity share of face value of Rs. 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter.

Issue Money Payable On
Opens on Closes On Application Allotment
24-Mar-26 27-Mar-26 392.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 38   Further Multiples of : 38
  Rs(Cr.) Lead Managers to the Issue
Project Cost 0.00 Arihant Capital Markets Limited
Project Financed through Current Offer 408.79  
Post Issue Equity Share Capital 23.67  
Issue Price 392.00  

Project

  • Capacity expansion and upgradation of manufacturing facilities
  • Establishment of a new R&D Centre
  • Repayment / prepayment of certain outstanding borrowings
  • Working capital requirements
  • Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
  • General corporate purposes

Promoted By

Anil Kumar Karusala

Vijitha Gorrepati

Karusala Aruna

Listing At

BSE

NSE

Registrar to the Issue

No Data Available